HepatoScore ‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk-Reference-Cited by-同舟云学术

HepatoScore ‐14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk

Published:2021-06 Issue:6 Volume:73 Page:2278-2292
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Morris Jeffrey S.¹^ORCID,Hassan Manal M.²,Zohner Ye Emma³,Wang Zeya³⁴,Xiao Lianchun⁵,Rashid Asif⁶,Haque Abedul⁷,Abdel‐Wahab Reham⁸^ORCID,Mohamed Yehia I.⁸,Ballard Karri L.⁹,Wolff Robert A.⁸,George Bhawana⁷,Li Liang⁵,Allen Genevera³¹⁰,Weylandt Michael³,Li Donghui⁸,Wang Wenyi⁴^ORCID,Raghav Kanwal⁸,Yao James⁸^ORCID,Amin Hesham M.⁷,Kaseb Ahmed Omar⁸

Affiliation:

1. Department of Biostatistics, Epidemiology, and Informatics Perelman School of Medicine University of Pennsylvania Philadelphia PA

2. Department of Epidemiology the University of Texas MD Anderson Cancer Center Houston TX

3. Department of Statistics Rice University Houston TX

4. Department of Bioinformatics and Computational Biology The University of Texas MD Anderson Cancer Center Houston TX

5. Department of Biostatistics The University of Texas MD Anderson Cancer Center Houston TX

6. Department of Pathology The University of Texas MD Anderson Cancer Center Houston TX

7. Department of Hematopathology the University of Texas MD Anderson Cancer Center Houston TX

8. Department of Gastrointestinal Medical Oncology the University of Texas MD Anderson Cancer Center Houston TX

9. Myriad RBM Inc. Austin TX

10. Department of Computer Science Rice University, Houston and Jan and Dan Duncan Neurological InstituteBaylor College of Medicine Houston TX

Funder

National Cancer Institute

National Institute of Environmental Health Sciences

National Science Foundation

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31555

Reference42 articles.

1. Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus

2. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case-control study

3. Association between hypothyroidism and hepatocellular carcinoma: A case-control study in the United States

4. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma

5. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2024-03

2. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features;The Oncologist;2023-12-30

3. An integrative view on glucagon function and putative role in the progression of pancreatic neuroendocrine tumours (pNETs) and hepatocellular carcinomas (HCC);Molecular and Cellular Endocrinology;2023-12

4. Incremental value of radiomics-based heterogeneity to the existing risk criteria in predicting recurrence of hepatocellular carcinoma after liver transplantation;European Radiology;2023-04-04

5. Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients;Oncotarget;2022-12-06